首页 > 最新文献

Steroids最新文献

英文 中文
Prednisone and ibuprofen conjugate Janus dendrimers and their anticancer activity 泼尼松和布洛芬共轭 Janus 树枝状聚合物及其抗癌活性
IF 2.7 4区 医学 Q2 Chemistry Pub Date : 2024-03-09 DOI: 10.1016/j.steroids.2024.109395
Israel Barajas-Mendoza , Irving Osiel Castillo-Rodríguez , Isabel Hernández-Rioja , Teresa Ramirez-Apan , Marcos Martínez-García

Drug release from hyperbranched Janus dendrimer-drug conjugates and their subsequent activity are influenced by the different drugs in each dendron and the linker. To understand these effects, we synthetized new Janus-type dendrimers of first and second generation. One dendron with 2,2-Bis(hydroxymethyl)propionic acid functionalized with ibuprofen and the second dendron was obtained with 3-aminopropanol-amidoamine and prednisone. The dendrimers were obtained by copper(I)-catalyzed Click azide-alkyne cycloaddition for the formation of a triazole as a dendrimeric nucleus of Janus dendrimer conjugates are reported.

The influence of ibuprofen, prednisone, and spacer on cancer activity of Janus dendrimers conjugates is reported. The IC50 values of the anticancer activity on cancer cell lines the Janus dendrimer of second generation was higher in comparison to the first generation dendrimer. Similarly, the anticancer activity was higher compared to the dendron conjugates. Also, no cytotoxic effects of dendrons and dendrimers on non-cancerous kidney COS-7 cell line was observed. The interesting anticancer activity of the prepared prednisone-ibuprofen Janus dendrimer conjugates suggest that the dendrimers could be of potential use as new anticancer drug.

超支化 Janus 树枝状分子-药物共轭物的药物释放及其后续活性受到每个树枝状分子和连接体中不同药物的影响。为了了解这些影响,我们合成了第一代和第二代新型 Janus 树枝状分子。其中一种树枝状化合物是用布洛芬功能化的 2,2-双(羟甲基)丙酸,第二种树枝状化合物是用 3-氨基丙醇-氨基胺和泼尼松。报告了通过铜(I)催化的叠氮-炔烃环加成形成三唑作为 Janus 树枝形分子共轭物的树枝形核而获得的树枝形分子。报告了布洛芬、泼尼松和间隔物对 Janus 树枝形分子共轭物抗癌活性的影响。与第一代树枝状聚合物相比,第二代 Janus 树枝状聚合物对癌细胞株的抗癌活性 IC50 值更高。同样,第二代 Janus 树枝状聚合物的抗癌活性也高于第一代树枝状聚合物。此外,还观察到树枝状化合物和树枝状聚合物对非癌症肾脏 COS-7 细胞系没有细胞毒性作用。所制备的泼尼松-布洛芬 Janus 树枝状聚合物共轭物的抗癌活性表明,这种树枝状聚合物有可能用作新的抗癌药物。
{"title":"Prednisone and ibuprofen conjugate Janus dendrimers and their anticancer activity","authors":"Israel Barajas-Mendoza ,&nbsp;Irving Osiel Castillo-Rodríguez ,&nbsp;Isabel Hernández-Rioja ,&nbsp;Teresa Ramirez-Apan ,&nbsp;Marcos Martínez-García","doi":"10.1016/j.steroids.2024.109395","DOIUrl":"10.1016/j.steroids.2024.109395","url":null,"abstract":"<div><p>Drug release from hyperbranched Janus dendrimer-drug conjugates and their subsequent activity are influenced by the different drugs in each dendron and the linker. To understand these effects, we synthetized new Janus-type dendrimers of first and second generation. One dendron with 2,2-Bis(hydroxymethyl)propionic acid functionalized with ibuprofen and the second dendron was obtained with 3-aminopropanol-amidoamine and prednisone. The dendrimers were obtained by copper(I)-catalyzed Click azide-alkyne cycloaddition for the formation of a triazole as a dendrimeric nucleus of Janus dendrimer conjugates are reported.</p><p>The influence of ibuprofen, prednisone, and spacer on cancer activity of Janus dendrimers conjugates is reported. The IC<sub>50</sub> values of the anticancer activity on cancer cell lines the Janus dendrimer of second generation was higher in comparison to the first generation dendrimer. Similarly, the anticancer activity was higher compared to the dendron conjugates. Also, no cytotoxic effects of dendrons and dendrimers on non-cancerous kidney COS-7 cell line was observed. The interesting anticancer activity of the prepared prednisone-ibuprofen Janus dendrimer conjugates suggest that the dendrimers could be of potential use as new anticancer drug.</p></div>","PeriodicalId":21997,"journal":{"name":"Steroids","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2024-03-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140077029","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Potential targets of diosgenin for the treatment of oral squamous cell carcinoma and their bioinformatics and transcriptional profiling analyses 地奥司明治疗口腔鳞状细胞癌的潜在靶点及其生物信息学和转录谱分析
IF 2.7 4区 医学 Q2 Chemistry Pub Date : 2024-03-06 DOI: 10.1016/j.steroids.2024.109393
Yang Xiao , Bingbing Xu , Xiaolan Li , Tianhao Ding , Wenxin Zhao , Xiaoxue Nie , Junxia Mu , Zhiyou Xiao , Qian Wang , Qunli Ren , Enkui Zhang

Diosgenin can inhibit the proliferation and cause apoptosis of various tumor cells, and its inhibitory effect on oral squamous cell carcinoma (OSCC) and its mechanism are still unclear. In this study, we predicted the targets of diosgenin for the treatment of OSCC through the database, then performed bioinformatics analysis of the targets, and further verified the effect of diosgenin on the activity of OSCC cell line HSC-3, the transcriptional profile of the targets and the molecular docking of the targets with diosgenin. The results revealed that there were 146 potential targets of diosgenin for OSCC treatment, which involved signaling pathways such as Ras, TNF, PI3K-AKT, HIF, NF-κB, and could regulate cellular activity through apoptosis, autophagy, proliferation and differentiation, inflammatory response, DNA repair, etc. Diosgenin significantly inhibited HSC-3 cell activity. The genes such as AKT1, MET1, SRC1, APP1, CCND1, MYC, PTGS2, AR, NFKB1, BIRC2, MDM2, BCL2L1, MMP2, may be important targets of its action, not only their expression was regulated by diosgenin but also their proteins had a high binding energy with diosgenin. These results suggest that diosgenin may have a therapeutic effect on OSCC through AKT1, MMP2 and other targets and multiple signaling pathways, which is of potential clinical value.

薯蓣皂苷能抑制多种肿瘤细胞的增殖并导致其凋亡,而其对口腔鳞状细胞癌(OSCC)的抑制作用及其机制尚不清楚。本研究通过数据库预测了薯蓣皂苷治疗OSCC的靶点,然后对靶点进行了生物信息学分析,并进一步验证了薯蓣皂苷对OSCC细胞株HSC-3活性的影响、靶点的转录谱以及靶点与薯蓣皂苷的分子对接。结果显示,薯蓣皂苷治疗OSCC的潜在靶点有146个,涉及Ras、TNF、PI3K-AKT、HIF、NF-κB等信号通路,可通过细胞凋亡、自噬、增殖和分化、炎症反应、DNA修复等调控细胞活性。薯蓣皂苷能明显抑制 HSC-3 细胞的活性。AKT1、MET1、SRC1、APP1、CCND1、MYC、PTGS2、AR、NFKB1、BIRC2、MDM2、BCL2L1、MMP2等基因可能是薯蓣皂苷的重要作用靶点,它们不仅表达受薯蓣皂苷调控,而且其蛋白与薯蓣皂苷的结合能很高。这些结果表明,薯蓣皂苷可能通过AKT1、MMP2等靶点和多种信号通路对OSCC产生治疗作用,具有潜在的临床价值。
{"title":"Potential targets of diosgenin for the treatment of oral squamous cell carcinoma and their bioinformatics and transcriptional profiling analyses","authors":"Yang Xiao ,&nbsp;Bingbing Xu ,&nbsp;Xiaolan Li ,&nbsp;Tianhao Ding ,&nbsp;Wenxin Zhao ,&nbsp;Xiaoxue Nie ,&nbsp;Junxia Mu ,&nbsp;Zhiyou Xiao ,&nbsp;Qian Wang ,&nbsp;Qunli Ren ,&nbsp;Enkui Zhang","doi":"10.1016/j.steroids.2024.109393","DOIUrl":"https://doi.org/10.1016/j.steroids.2024.109393","url":null,"abstract":"<div><p>Diosgenin can inhibit the proliferation and cause apoptosis of various tumor cells, and its inhibitory effect on oral squamous cell carcinoma (OSCC) and its mechanism are still unclear. In this study, we predicted the targets of diosgenin for the treatment of OSCC through the database, then performed bioinformatics analysis of the targets, and further verified the effect of diosgenin on the activity of OSCC cell line HSC-3, the transcriptional profile of the targets and the molecular docking of the targets with diosgenin. The results revealed that there were 146 potential targets of diosgenin for OSCC treatment, which involved signaling pathways such as Ras, TNF, PI3K-AKT, HIF, NF-κB, and could regulate cellular activity through apoptosis, autophagy, proliferation and differentiation, inflammatory response, DNA repair, etc. Diosgenin significantly inhibited HSC-3 cell activity. The genes such as <em>AKT1</em>, <em>MET1</em>, <em>SRC1</em>, <em>APP1</em>, <em>CCND1</em>, <em>MYC</em>, <em>PTGS2</em>, <em>AR</em>, <em>NFKB1</em>, <em>BIRC2</em>, <em>MDM2</em>, <em>BCL2L1</em>, <em>MMP2</em>, may be important targets of its action, not only their expression was regulated by diosgenin but also their proteins had a high binding energy with diosgenin. These results suggest that diosgenin may have a therapeutic effect on OSCC through AKT1, MMP2 and other targets and multiple signaling pathways, which is of potential clinical value.</p></div>","PeriodicalId":21997,"journal":{"name":"Steroids","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2024-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140063286","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effect of vitamin D2 supplementation on vitamin D levels in humans: A time and dose–response meta-analysis of randomized controlled trials 补充维生素 D2 对人体维生素 D 水平的影响:随机对照试验的时间和剂量反应荟萃分析。
IF 2.7 4区 医学 Q2 Chemistry Pub Date : 2024-03-06 DOI: 10.1016/j.steroids.2024.109394
Fan Zhou , Abdolreza Jamilian , Kousalya Prabahar , Benjamin Hernández-Wolters , Hamed Kord-Varkaneh , Dunyao Bai

Background

Inconsistencies exist regarding the influence of vitamin D2 (ergocalciferol) supplementation on serum vitamin D levels. These inconsistencies could be attributed to numerous factors, such as dosage, baseline vitamin D levels, and duration of intervention. Hence, this dose–response meta-analysis of randomized controlled trials was conducted to assess the efficacy of vitamin D2 supplementation on vitamin D levels.

Methods

Relevant studies were searched in PubMed/Medline, Web of Science, Embase, and Scopus, from their inception to 3 January 2023. Variable alterations were considered to calculate the pooled weighted mean difference (WMD) with 95% confidence interval (CI) using the random effects model.

Results

Pooled results from 33 study arms demonstrated that Vitamin D2 treatment significantly increases total vitamin D concentrations (WMD: 11.47 ng/mL, 95 %CI: 9.29 to 13.64, p < 0.001), 25(OH)D2 concentrations (WMD: 11.40 ng/mL, 95 %CI: 4.72 to 18.09, p = 0.001), and 1,25(OH)D concentrations (WMD: 5.61 ng/mL, 95 %CI: 0.74 to 10.48, p = 0.024), but decreases 25(OH)D3 concentrations (WMD: −4.63 ng/mL, 95 %CI: −6.46 to −2.81, p < 0.001). In subgroup analyses, increase in total vitamin D concentrations was more significant in vitamin D2 doses >2000 IU/day (WMD: 13.82 ng/mL), studies with duration ≤12 weeks (WMD: 12.53 ng/mL), participants aged ≥60 years (WMD: 14.40 ng/mL), and trials with basal 25(OH)D concentrations <20 ng/mL (WMD: 11.47 ng/mL).

Conclusions

This meta-analysis indicates that the supplementation of vitamin D2 significantly increases the serum concentrations of total vitamin D, 25(OH)D2, and 1,25(OH)D, but decreases 25(OH)D3 concentrations. Careful consideration of patient characteristics, dosage, and treatment duration is recommended for vitamin D2 supplementation.

背景:维生素 D2(麦角钙化醇)补充剂对血清维生素 D 水平的影响存在不一致之处。这些不一致可归因于多种因素,如剂量、基线维生素 D 水平和干预持续时间。因此,本研究对随机对照试验进行了剂量-反应荟萃分析,以评估补充维生素 D2 对维生素 D 水平的疗效:方法:在 PubMed/Medline、Web of Science、Embase 和 Scopus 中检索了从开始到 2023 年 1 月 3 日的相关研究。采用随机效应模型计算加权平均差(WMD)和95%置信区间(CI):来自 33 个研究臂的汇总结果表明,维生素 D2 治疗可显著提高总维生素 D 浓度(WMD:11.47 ng/mL,95 %CI:9.29 至 13.64,p 2000 IU/天(WMD:13.82 ng/mL))、持续时间≤12 周的研究(WMD:12.53 ng/mL)、年龄≥60 岁的参与者(WMD:14.40 ng/mL)以及基础 25(OH)D 浓度的试验结论:这项荟萃分析表明,补充维生素 D2 可显著提高血清中总维生素 D、25(OH)D2 和 1,25(OH)D 的浓度,但会降低 25(OH)D3 的浓度。建议在补充维生素 D2 时仔细考虑患者的特征、剂量和治疗持续时间。
{"title":"The effect of vitamin D2 supplementation on vitamin D levels in humans: A time and dose–response meta-analysis of randomized controlled trials","authors":"Fan Zhou ,&nbsp;Abdolreza Jamilian ,&nbsp;Kousalya Prabahar ,&nbsp;Benjamin Hernández-Wolters ,&nbsp;Hamed Kord-Varkaneh ,&nbsp;Dunyao Bai","doi":"10.1016/j.steroids.2024.109394","DOIUrl":"10.1016/j.steroids.2024.109394","url":null,"abstract":"<div><h3>Background</h3><p>Inconsistencies exist regarding the influence of vitamin D2 (ergocalciferol) supplementation on serum vitamin D levels. These inconsistencies could be attributed to numerous factors, such as dosage, baseline vitamin D levels, and duration of intervention. Hence, this dose–response meta-analysis of randomized controlled trials was conducted to assess the efficacy of vitamin D2 supplementation on vitamin D levels.</p></div><div><h3>Methods</h3><p>Relevant studies were searched in PubMed/Medline, Web of Science, Embase, and Scopus, from their inception to 3 January 2023. Variable alterations were considered to calculate the pooled weighted mean difference (WMD) with 95% confidence interval (CI) using the random effects model.</p></div><div><h3>Results</h3><p>Pooled results from 33 study arms demonstrated that Vitamin D2 treatment significantly increases total vitamin D concentrations (WMD: 11.47 ng/mL, 95 %CI: 9.29 to 13.64, p &lt; 0.001), 25(OH)D2 concentrations (WMD: 11.40 ng/mL, 95 %CI: 4.72 to 18.09, p = 0.001), and 1,25(OH)D concentrations (WMD: 5.61 ng/mL, 95 %CI: 0.74 to 10.48, p = 0.024), but decreases 25(OH)D3 concentrations (WMD: −4.63 ng/mL, 95 %CI: −6.46 to −2.81, p &lt; 0.001). In subgroup analyses, increase in total vitamin D concentrations was more significant in vitamin D2 doses &gt;2000 IU/day (WMD: 13.82 ng/mL), studies with duration ≤12 weeks (WMD: 12.53 ng/mL), participants aged ≥60 years (WMD: 14.40 ng/mL), and trials with basal 25(OH)D concentrations &lt;20 ng/mL (WMD: 11.47 ng/mL).</p></div><div><h3>Conclusions</h3><p>This meta-analysis indicates that the supplementation of vitamin D2 significantly increases the serum concentrations of total vitamin D, 25(OH)D2, and 1,25(OH)D, but decreases 25(OH)D3 concentrations. Careful consideration of patient characteristics, dosage, and treatment duration is recommended for vitamin D2 supplementation.</p></div>","PeriodicalId":21997,"journal":{"name":"Steroids","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2024-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140065986","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bio-oxidation of progesterone by Penicillium oxalicum CBMAI 1185 and evaluation of the cytotoxic activity 草酸青霉 CBMAI 1185 对黄体酮的生物氧化作用及细胞毒性活性评估。
IF 2.7 4区 医学 Q2 Chemistry Pub Date : 2024-03-05 DOI: 10.1016/j.steroids.2024.109392
Thayane Melo de Queiroz , Talita A. Valdes , Andrei Leitão , André L.M. Porto

We report the biotransformation of progesterone 1 by whole cells of Brazilian marine-derived fungi. A preliminary screening with 12 fungi revealed that the strains Penicillium oxalicum CBMAI 1996, Mucor racemous CBMAI 847, Cladosporium sp. CBMAI 1237, Penicillium oxalicum CBMAI 1185 and Aspergillus sydowii CBMAI 935 were efficient in the biotransformation of progesterone 1 in the first days of the reaction, with conversion values ranging from 75 % to 99 %. The fungus P. oxalicum CBMAI 1185 was employed in the reactions in quintuplicate to purify and characterize the main biotransformation products of progesterone 1. The compounds testololactone 1a, 12β-hydroxyandrostenedione 1b and 1β-hydroxyandrostenedione 1c were isolated and characterized by NMR, MS, [α]D and MP. In addition, the chromatographic yield of compound 1a was determined by HPLC-PDA in the screening experiments. In this study, we show a biotransformation pathway of progesterone 1, suggesting the presence of several enzymes such as Baeyer-Villiger monooxygenases, dehydrogenases and cytochrome P450 monooxygenases in the fungus P. oxalicum CBMAI 1185. In summary, the results obtained in this study contribute to the synthetic area and have environmental importance, since the marine-derived fungi can be employed in the biodegradation of steroids present in wastewater and the environment. The cytotoxic results demonstrate that the biodegradation products were inactive against the cell lines, in contrast to progesterone.

我们报告了巴西海洋源真菌全细胞对孕酮 1 的生物转化。通过对 12 种真菌的初步筛选发现,草拟青霉 CBMAI 1996、外消旋真菌 CBMAI 847、Cladosporium sp.CBMAI 1237、草拟青霉 CBMAI 1185 和西多威曲霉 CBMAI 935 菌株在反应的最初几天能有效地对黄体酮 1 进行生物转化,转化率从 75 % 到 99 % 不等。真菌 P. oxalicum CBMAI 1185 被用于一式五份的反应,以纯化和鉴定黄体酮 1 的主要生物转化产物。分离出了睾酮内酯 1a、12β-羟基雄烯二酮 1b 和 1β-羟基雄烯二酮 1c,并通过核磁共振、质谱、[α]D 和 mp 进行了表征。此外,在筛选实验中,通过 HPLC-PDA 测定了化合物 1a 的色谱产率。在本研究中,我们展示了黄体酮 1 的生物转化途径,表明真菌草履虫 CBMAI 1185 中存在多种酶,如拜尔-维利格单氧酶、脱氢酶和细胞色素 P450 单氧酶。总之,本研究获得的结果有助于合成领域,对环境具有重要意义,因为海洋源真菌可用于废水和环境中类固醇的生物降解。细胞毒性结果表明,与黄体酮相比,生物降解产物对细胞株无活性。
{"title":"Bio-oxidation of progesterone by Penicillium oxalicum CBMAI 1185 and evaluation of the cytotoxic activity","authors":"Thayane Melo de Queiroz ,&nbsp;Talita A. Valdes ,&nbsp;Andrei Leitão ,&nbsp;André L.M. Porto","doi":"10.1016/j.steroids.2024.109392","DOIUrl":"10.1016/j.steroids.2024.109392","url":null,"abstract":"<div><p>We report the biotransformation of progesterone <strong>1</strong> by whole cells of Brazilian marine-derived fungi. A preliminary screening with 12 fungi revealed that the strains <em>Penicillium oxalicum</em> CBMAI 1996, <em>Mucor racemous</em> CBMAI 847, <em>Cladosporium</em> sp. CBMAI 1237, <em>Penicillium oxalicum</em> CBMAI 1185 and <em>Aspergillus sydowii</em> CBMAI 935 were efficient in the biotransformation of progesterone <strong>1</strong> in the first days of the reaction, with conversion values ranging from 75 % to 99 %. The fungus <em>P. oxalicum</em> CBMAI 1185 was employed in the reactions in quintuplicate to purify and characterize the main biotransformation products of progesterone <strong>1</strong>. The compounds testololactone <strong>1a</strong>, 12<em>β</em>-hydroxyandrostenedione <strong>1b</strong> and 1<em>β</em>-hydroxyandrostenedione <strong>1c</strong> were isolated and characterized by NMR, MS, [α]<sub>D</sub> and MP. In addition, the chromatographic yield of compound <strong>1a</strong> was determined by HPLC-PDA in the screening experiments. In this study, we show a biotransformation pathway of progesterone <strong>1</strong>, suggesting the presence of several enzymes such as Baeyer-Villiger monooxygenases, dehydrogenases and cytochrome P450 monooxygenases in the fungus <em>P. oxalicum</em> CBMAI 1185. In summary, the results obtained in this study contribute to the synthetic area and have environmental importance, since the marine-derived fungi can be employed in the biodegradation of steroids present in wastewater and the environment. The cytotoxic results demonstrate that the biodegradation products were inactive against the cell lines, in contrast to progesterone.</p></div>","PeriodicalId":21997,"journal":{"name":"Steroids","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2024-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140060534","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A unified total synthesis route to 18-trideuterated and/or 19-trideuterated testosterone, androstenedione and progesterone 18 三氚化和/或 19 三氚化睾酮、雄烯二酮和孕酮的统一全合成途径。
IF 2.7 4区 医学 Q2 Chemistry Pub Date : 2024-03-02 DOI: 10.1016/j.steroids.2024.109391
Mingxing Qian , Douglas F. Covey

A unified total synthesis route has been used to prepare 18- and 19-trideuterated testosterone, androstenedione and progesterone. The 18-trideuterated steroid synthetic method starts with the synthesis of 2-(methyl-d3)-1,3-cyclopentanedione from CD3I and 1,3-cyclopentanedione and is subsequently converted into the Hajos-Parrish ketone for synthesis of these trideuterated steroids. The 19-trideuterated steroid synthesis proceeds through non-deuterated Hajos-Parrish ketone with incorporation of the 19-methyl-d3 group from CD3I at a later stage of the same synthetic route. Utilization of CD3I at both the initial and later stages of the synthesis provides a route to 18,19-hexadeuterated steroids. The deuterated steroids are useful for studies of steroid biosynthesis and metabolism.

采用统一的全合成路线制备 18 和 19 三氚代睾酮、雄烯二酮和孕酮。18 三氚代类固醇合成法首先从 CD3I 和 1,3- 环戊二酮合成 2-(甲基-d3)-1,3-环戊二酮,然后转化为 Hajos-Parrish 酮,以合成这些三氚代类固醇。19 三氚代类固醇的合成是通过非氚代 Hajos-Parrish 酮进行的,并在同一合成路线的后期阶段加入 CD3I 的 19-甲基-d3 基团。在合成的初始阶段和后期阶段利用 CD3I 提供了一条获得 18、19-六氘代类固醇的途径。氘代类固醇有助于类固醇生物合成和代谢的研究。
{"title":"A unified total synthesis route to 18-trideuterated and/or 19-trideuterated testosterone, androstenedione and progesterone","authors":"Mingxing Qian ,&nbsp;Douglas F. Covey","doi":"10.1016/j.steroids.2024.109391","DOIUrl":"10.1016/j.steroids.2024.109391","url":null,"abstract":"<div><p>A unified total synthesis route has been used to prepare 18- and 19-trideuterated testosterone, androstenedione and progesterone. The 18-trideuterated steroid synthetic method starts with the synthesis of 2-(methyl-d3)-1,3-cyclopentanedione from CD3I and 1,3-cyclopentanedione and is subsequently converted into the Hajos-Parrish ketone for synthesis of these trideuterated steroids. The 19-trideuterated steroid synthesis proceeds through non-deuterated Hajos-Parrish ketone with incorporation of the 19-methyl-d3 group from CD3I at a later stage of the same synthetic route. Utilization of CD3I at both the initial and later stages of the synthesis provides a route to 18,19-hexadeuterated steroids. The deuterated steroids are useful for studies of steroid biosynthesis and metabolism.</p></div>","PeriodicalId":21997,"journal":{"name":"Steroids","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2024-03-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140029079","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New ring-A modified cycloartane triterpenoids from Dysoxylum malabaricum bark: Isolation, structure elucidation and their cytotoxicity Dysoxylum malabaricum 树皮中新的环-A 改性环莰烷三萜类化合物:分离、结构阐释及其细胞毒性
IF 2.7 4区 医学 Q2 Chemistry Pub Date : 2024-02-16 DOI: 10.1016/j.steroids.2024.109390
Nivedita Bhardwaj , Priyamvada Gupta , Nancy Tripathi , Sanheeta Chakrabarty , Ashish Verma , Sanju Kumari , Vibhav Gautam , G. Ravikanth , Shreyans K. Jain

The Genus Dysoxylum (Meliaceae) consists of approximately 80 species that are abundant in structurally diverse triterpenoids. The present study focused on isolating new triterpenoids from the bark of Dysoxylum malabaricum, one of the predominant species of Dysoxylum present in India. The methanol-dichloromethane bark extract was subjected to LCMS profiling followed by silica gel column chromatography and HPLC analysis to target new compounds. Two new ring A-modified cycloartane-type triterpenoids (1 and 2) were isolated from the bark extract. Spectroscopic methods like NMR, HRESIMS data, and electronic circular dichroism calculations elucidated the structures and absolute configurations of the isolated compounds. These compounds were evaluated for their cytotoxic potential against breast cancer cells and displayed notable cytotoxicity. Compound 1 exhibited the highest cytotoxicity against the MDA-MB-231 cells and induced apoptotic cell death. Also, it was able to inhibit glucose uptake and increase nitric oxide production in breast cancer cells.

Dysoxylum 属(旋花科)由大约 80 个物种组成,这些物种富含结构多样的三萜类化合物。本研究的重点是从 Dysoxylum malabaricum(印度主要的 Dysoxylum 物种之一)树皮中分离出新的三萜类化合物。对甲醇-二氯甲烷树皮提取物进行了 LCMS 分析,然后进行了硅胶柱层析和 HPLC 分析,以确定新的化合物。从树皮提取物中分离出了两种新的环 A 改性环安坦类三萜类化合物(1 和 2)。核磁共振、HRESIMS 数据和电子圆二色性计算等光谱方法阐明了分离出的化合物的结构和绝对构型。评估了这些化合物对乳腺癌细胞的细胞毒性潜力,结果显示它们具有显著的细胞毒性。化合物 1 对 MDA-MB-231 细胞的细胞毒性最高,能诱导细胞凋亡。此外,它还能抑制乳腺癌细胞对葡萄糖的摄取并增加一氧化氮的产生。
{"title":"New ring-A modified cycloartane triterpenoids from Dysoxylum malabaricum bark: Isolation, structure elucidation and their cytotoxicity","authors":"Nivedita Bhardwaj ,&nbsp;Priyamvada Gupta ,&nbsp;Nancy Tripathi ,&nbsp;Sanheeta Chakrabarty ,&nbsp;Ashish Verma ,&nbsp;Sanju Kumari ,&nbsp;Vibhav Gautam ,&nbsp;G. Ravikanth ,&nbsp;Shreyans K. Jain","doi":"10.1016/j.steroids.2024.109390","DOIUrl":"10.1016/j.steroids.2024.109390","url":null,"abstract":"<div><p>The Genus Dysoxylum (Meliaceae) consists of approximately 80 species that are abundant in structurally diverse triterpenoids. The present study focused on isolating new triterpenoids from the bark of <em>Dysoxylum malabaricum,</em> one of the predominant species of Dysoxylum present in India. The methanol-dichloromethane bark extract was subjected to LCMS profiling followed by silica gel column chromatography and HPLC analysis to target new compounds. Two new ring A-modified cycloartane-type triterpenoids (<strong>1</strong> and <strong>2</strong>) were isolated from the bark extract<em>.</em> Spectroscopic methods like NMR, HRESIMS data, and electronic circular dichroism calculations elucidated the structures<!--> <!-->and<!--> <!-->absolute configurations of the isolated compounds. These compounds were evaluated for their cytotoxic potential against breast cancer cells and displayed notable cytotoxicity. Compound <strong>1</strong> exhibited the highest cytotoxicity against the MDA-MB-231 cells and induced apoptotic cell death. Also, it was able to inhibit glucose uptake and increase nitric oxide production in breast cancer cells.</p></div>","PeriodicalId":21997,"journal":{"name":"Steroids","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2024-02-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139773871","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New ring-A modified cycloartane triterpenoids from Dysoxylum malabaricum Bark: Isolation, structure elucidation and their cytotoxicity Dysoxylum malabaricum 树皮中新的环-A 改性环莰烷三萜类化合物:分离、结构阐释及其细胞毒性
IF 2.7 4区 医学 Q2 Chemistry Pub Date : 2024-02-16 DOI: 10.1016/j.steroids.2024.109390
Nivedita Bhardwaj, Priyamvada Gupta, Nancy Tripathi, Sanheeta Chakarbarty, Ashish Verma, Sanju Kumari, Vibhav Gautam, G. Ravikanth, Shreyans K. Jain
{"title":"New ring-A modified cycloartane triterpenoids from Dysoxylum malabaricum Bark: Isolation, structure elucidation and their cytotoxicity","authors":"Nivedita Bhardwaj, Priyamvada Gupta, Nancy Tripathi, Sanheeta Chakarbarty, Ashish Verma, Sanju Kumari, Vibhav Gautam, G. Ravikanth, Shreyans K. Jain","doi":"10.1016/j.steroids.2024.109390","DOIUrl":"https://doi.org/10.1016/j.steroids.2024.109390","url":null,"abstract":"","PeriodicalId":21997,"journal":{"name":"Steroids","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2024-02-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139833604","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparing the efficacy of corticosteroids among patients with community-acquired pneumonia in the ICU versus non-ICU settings: A systematic review and meta-analysis 比较重症监护病房与非重症监护病房社区获得性肺炎患者使用皮质类固醇的疗效:系统回顾和荟萃分析
IF 2.7 4区 医学 Q2 Chemistry Pub Date : 2024-02-13 DOI: 10.1016/j.steroids.2024.109389
Luis A. Diaz Caballero , Ashnah Aijaz , Neha Saleem Paryani , Samar Mahmood , Madiha Salman , Mohammad Omer Khan , Dayal Ahluwalia , Mohammad Arham Siddiq , Ishaque Hameed

Background

Despite the potential of corticosteroids in treating community-acquired pneumonia (CAP), conflicting evidence exists regarding their effect on mortality. To address this gap and provide new insights, we conducted a pre-specified subgroup meta-analysis of corticosteroid use in CAP patients, focusing on the ICU versus non-ICU subsets.

Methods

We searched PubMed, Cochrane Central Register of Controlled Trials and SCOPUS from inception to May 2023 for randomized controlled trials (RCTs). The primary outcomes of interest were mortality, need for mechanical ventilation, need for ICU admission, and treatment failure. Secondary outcomes analysed were the need for hospital readmission, length of hospital stay, length of ICU stay, gastrointestinal (GI) bleeding, secondary infections, and hyperglycaemic events. The results were analysed through the random-effects model. A p-value < 0.05 was considered significant.

Results

Eighteen randomized controlled trials (n = 4472) analyzing patients with CAP were included. Our results suggest that corticosteroids significantly reduced the incidence of mortality (RR: 0.66; 95 % CI: 0.54, 0.81; P = <0.0001) and need for mechanical ventilation (RR: 0.57; 95 % CI: 0.44, 0.73; P = <0.00001). It was also observed that corticosteroids significantly decrease the lengths of ICU (MD: −1.67; 95 % CI: −2.97, −0.37; P = 0.01) and hospital stay (MD: −1.94; 95 % CI: −2.89, −0.98; P = 0.0001), while increasing the number of hyperglycemic events (RR: 1.68; 95 % CI: 1.32, 2.12; P = <0.0001) and hospital readmissions (RR: 1.19; 95 % CI: 1.04, 1.37; P = 0.01).

Conclusions

The results of this meta-analysis demonstrate that corticosteroids yield improved outcomes in CAP patients with regard to reduced mortality and the need for mechanical ventilation. It highlights the need for further large-scale RCTs with the proposed, specific stratifications.

背景尽管皮质类固醇具有治疗社区获得性肺炎(CAP)的潜力,但关于其对死亡率的影响却存在相互矛盾的证据。为了填补这一空白并提供新的见解,我们对 CAP 患者使用皮质类固醇的情况进行了预先指定的亚组荟萃分析,重点关注 ICU 与非 ICU 亚组。主要研究结果包括死亡率、机械通气需求、入住重症监护室需求和治疗失败。次要分析结果包括再入院需求、住院时间、重症监护室住院时间、消化道(GI)出血、继发感染和高血糖事件。结果通过随机效应模型进行分析。结果共纳入 18 项随机对照试验(n = 4472),对 CAP 患者进行了分析。结果表明,皮质类固醇可明显降低死亡率(RR:0.66;95 % CI:0.54,0.81;P = <0.0001)和机械通气需求(RR:0.57;95 % CI:0.44,0.73;P = <0.00001)。研究还发现,皮质类固醇可明显缩短重症监护室(MD:-1.67;95 % CI:-2.97,-0.37;P = 0.01)和住院时间(MD:-1.94;95 % CI:-2.89,-0.98;P = 0.0001),同时增加高血糖事件的次数(RR:1.68;95 % CI:1.结论这项荟萃分析结果表明,皮质类固醇可改善 CAP 患者的预后,降低死亡率和机械通气需求。荟萃分析结果表明,皮质类固醇可改善 CAP 患者的预后,降低死亡率和机械通气需求。
{"title":"Comparing the efficacy of corticosteroids among patients with community-acquired pneumonia in the ICU versus non-ICU settings: A systematic review and meta-analysis","authors":"Luis A. Diaz Caballero ,&nbsp;Ashnah Aijaz ,&nbsp;Neha Saleem Paryani ,&nbsp;Samar Mahmood ,&nbsp;Madiha Salman ,&nbsp;Mohammad Omer Khan ,&nbsp;Dayal Ahluwalia ,&nbsp;Mohammad Arham Siddiq ,&nbsp;Ishaque Hameed","doi":"10.1016/j.steroids.2024.109389","DOIUrl":"https://doi.org/10.1016/j.steroids.2024.109389","url":null,"abstract":"<div><h3>Background</h3><p>Despite the potential of corticosteroids in treating community-acquired pneumonia (CAP), conflicting evidence exists regarding their effect on mortality. To address this gap and provide new insights, we conducted a pre-specified subgroup <em>meta</em>-analysis of corticosteroid use in CAP patients, focusing on the ICU versus non-ICU subsets.</p></div><div><h3>Methods</h3><p>We searched PubMed, Cochrane Central Register of Controlled Trials and SCOPUS from inception to May 2023 for randomized controlled trials (RCTs). The primary outcomes of interest were mortality, need for mechanical ventilation, need for ICU admission, and treatment failure. Secondary outcomes analysed were the need for hospital readmission, length of hospital stay, length of ICU stay, gastrointestinal (GI) bleeding, secondary infections, and hyperglycaemic events. The results were analysed through the random-effects model. A p-value &lt; 0.05 was considered significant.</p></div><div><h3>Results</h3><p>Eighteen randomized controlled trials (n = 4472) analyzing patients with<!--> <!-->CAP were included. Our results suggest that corticosteroids significantly reduced the incidence of mortality (RR: 0.66; 95 % CI: 0.54, 0.81; P = &lt;0.0001) and need for mechanical ventilation (RR: 0.57; 95 % CI: 0.44, 0.73; P = &lt;0.00001). It was also observed that corticosteroids significantly decrease the lengths of ICU (MD: −1.67; 95 % CI: −2.97, −0.37; P = 0.01) and hospital stay (MD: −1.94; 95 % CI: −2.89, −0.98; P = 0.0001), while increasing the number of hyperglycemic events (RR: 1.68; 95 % CI: 1.32, 2.12; P = &lt;0.0001) and hospital readmissions (RR: 1.19; 95 % CI: 1.04, 1.37; P = 0.01).</p></div><div><h3>Conclusions</h3><p>The results of this <em>meta</em>-analysis demonstrate that corticosteroids yield improved outcomes in CAP patients with regard to reduced mortality and the need for mechanical ventilation. It highlights the need for further large-scale RCTs with the proposed, specific stratifications.</p></div>","PeriodicalId":21997,"journal":{"name":"Steroids","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2024-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139733364","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An asiatic acid derived trisulfamate acts as a nanomolar inhibitor of human carbonic anhydrase VA 一种茜草酸衍生的三氨基磺酸盐是人碳酸酐酶 VA 的纳摩尔级抑制剂
IF 2.7 4区 医学 Q2 Chemistry Pub Date : 2024-02-05 DOI: 10.1016/j.steroids.2024.109381
Toni C. Denner , Niels V. Heise , Immo Serbian , Andrea Angeli , Claudiu T. Supuran , René Csuk

This investigation delves into the inhibitory capabilities of a specific set of triterpenoic acids on diverse isoforms of human carbonic anhydrase (hCA). Oleanolic acid (1), maslinic acid (2), betulinic acid (3), platanic acid (4), and asiatic acid (5) were chosen as representative triterpenoids for evaluation. The synthesis involved acetylation of parent triterpenoic acids 15, followed by sequential reactions with oxalyl chloride and benzylamine, de-acetylation of the amides, and subsequent treatment with sodium hydride and sulfamoyl chloride, leading to the formation of final compounds 2125.

Inhibition assays against hCAs I, II, VA, and IX demonstrated noteworthy outcomes. A derivative of betulinic acid, compound 23, exhibited a Ki value of 88.1 nM for hCA VA, and a derivative of asiatic acid, compound 25, displayed an even lower Ki value of 36.2 nM for the same isoform. Notably, the latter compound displayed enhanced inhibitory activity against hCA VA when compared to the benchmark compound acetazolamide (AAZ), which had a Ki value of 63.0 nM. Thus, this compound surpasses the inhibitory potency and isoform selectivity of the standard compound acetazolamide (AAZ). In conclusion, the research offers insights into the inhibitory potential of selected triterpenoic acids across diverse hCA isoforms, emphasizing the pivotal role of structural attributes in determining isoform-specific inhibitory activity. The identification of compound 25 as a robust and selective hCA VA inhibitor prompts further exploration of its therapeutic applications.

本研究探讨了一组特定的三萜酸对人类碳酸酐酶(hCA)不同异构体的抑制能力。齐墩果酸(1)、马斯林酸(2)、白桦林酸(3)、铂酸(4)和积雪草酸(5)被选为具有代表性的三萜类化合物进行评估。合成过程包括对母体三萜酸 1-5 进行乙酰化,然后依次与草酰氯和苄胺反应,对酰胺进行脱乙酰化,最后用氢化钠和氨基磺酰氯处理,形成最终化合物 21-25。白桦脂酸的衍生物 23 号化合物对 hCA VA 的 Ki 值为 88.1 nM,而积雪草酸的衍生物 25 号化合物对同一异构体的 Ki 值更低,仅为 36.2 nM。值得注意的是,与 Ki 值为 63.0 nM 的基准化合物乙酰唑胺(AAZ)相比,后一种化合物对 hCA VA 的抑制活性更强。因此,该化合物超越了标准化合物乙酰唑胺(AAZ)的抑制效力和同工酶选择性。总之,这项研究深入揭示了所选三萜酸对不同 hCA 同工酶的抑制潜力,强调了结构属性在决定同工酶特异性抑制活性中的关键作用。化合物 25 是一种强效且具有选择性的 hCA VA 抑制剂,这促使人们进一步探索它的治疗应用。
{"title":"An asiatic acid derived trisulfamate acts as a nanomolar inhibitor of human carbonic anhydrase VA","authors":"Toni C. Denner ,&nbsp;Niels V. Heise ,&nbsp;Immo Serbian ,&nbsp;Andrea Angeli ,&nbsp;Claudiu T. Supuran ,&nbsp;René Csuk","doi":"10.1016/j.steroids.2024.109381","DOIUrl":"10.1016/j.steroids.2024.109381","url":null,"abstract":"<div><p>This investigation delves into the inhibitory capabilities of a specific set of triterpenoic acids on diverse isoforms of human carbonic anhydrase (<em>h</em>CA). Oleanolic acid (<strong>1</strong>), maslinic acid (<strong>2</strong>), betulinic acid (<strong>3</strong>), platanic acid (<strong>4</strong>), and asiatic acid (<strong>5</strong>) were chosen as representative triterpenoids for evaluation. The synthesis involved acetylation of parent triterpenoic acids <strong>1</strong>–<strong>5</strong>, followed by sequential reactions with oxalyl chloride and benzylamine, de-acetylation of the amides, and subsequent treatment with sodium hydride and sulfamoyl chloride, leading to the formation of final compounds <strong>21</strong>–<strong>25</strong>.</p><p>Inhibition assays against <em>h</em>CAs I, II, VA, and IX demonstrated noteworthy outcomes. A derivative of betulinic acid, compound <strong>23</strong>, exhibited a K<sub>i</sub> value of 88.1 nM for <em>h</em>CA VA, and a derivative of asiatic acid, compound <strong>25</strong>, displayed an even lower K<sub>i</sub> value of 36.2 nM for the same isoform. Notably, the latter compound displayed enhanced inhibitory activity against <em>h</em>CA VA when compared to the benchmark compound acetazolamide (<strong>AAZ</strong>), which had a K<sub>i</sub> value of 63.0 nM. Thus, this compound surpasses the inhibitory potency and isoform selectivity of the standard compound acetazolamide (<strong>AAZ</strong>). In conclusion, the research offers insights into the inhibitory potential of selected triterpenoic acids across diverse <em>h</em>CA isoforms, emphasizing the pivotal role of structural attributes in determining isoform-specific inhibitory activity. The identification of compound <strong>25</strong> as a robust and selective <em>h</em>CA VA inhibitor prompts further exploration of its therapeutic applications.</p></div>","PeriodicalId":21997,"journal":{"name":"Steroids","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2024-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0039128X24000199/pdfft?md5=d1e571a1eb85d63517d40e8bf9284312&pid=1-s2.0-S0039128X24000199-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139683160","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Filamin A in triple negative breast cancer 三阴性乳腺癌中的丝胶蛋白 A。
IF 2.7 4区 医学 Q2 Chemistry Pub Date : 2024-02-02 DOI: 10.1016/j.steroids.2024.109380
Pia Giovannelli, Marzia Di Donato, Fabrizio Licitra, Emilia Sabbatino, Viviana Tutino, Gabriella Castoria, Antimo Migliaccio

Triple-negative breast cancer is a rare but highly heterogeneous breast cancer subtype with a limited choice of specific treatments. Chemotherapy remains the only efficient treatment, but its side effects and the development of resistance consolidate the urgent need to discover new targets. In TNBC, filamin A expression correlates to grade and TNM stage. Accordingly, this protein could constitute a new target for this BC subtype. Even if most of the data indicates its direct involvement in cancer progression, some contrasting results underline the need to deepen the studies. To elucidate a possible function of this protein as a TNBC marker, we summarized the main characteristic of filamin A and its involvement in physiological and pathological processes such as cancer. Lastly, we scrutinized its actions in triple-negative breast cancer and highlighted the need to increase the number of studies useful to better clarify the role of this versatile protein as a marker and target in TNBC, alone or in “collaboration” with other proteins with a relevant role in this BC subgroup.

三阴性乳腺癌是一种罕见但高度异质性的乳腺癌亚型,可供选择的特异性治疗方法有限。化疗仍然是唯一有效的治疗方法,但化疗的副作用和耐药性的产生使得发现新靶点的需求更加迫切。在 TNBC 中,丝胶蛋白 A 的表达与分级和 TNM 分期相关。因此,该蛋白可能成为这一BC亚型的新靶点。尽管大多数数据表明,丝胶蛋白 A 直接参与了癌症的进展,但一些截然不同的结果也凸显了深化研究的必要性。为了阐明该蛋白作为 TNBC 标志物的可能功能,我们总结了丝胺 A 的主要特征及其在癌症等生理和病理过程中的参与。最后,我们仔细研究了丝胶蛋白 A 在三阴性乳腺癌中的作用,并强调需要增加有用的研究数量,以更好地阐明这种多功能蛋白作为 TNBC 标志物和靶点的作用,无论是单独作用还是与其他蛋白 "合作 "作用。
{"title":"Filamin A in triple negative breast cancer","authors":"Pia Giovannelli,&nbsp;Marzia Di Donato,&nbsp;Fabrizio Licitra,&nbsp;Emilia Sabbatino,&nbsp;Viviana Tutino,&nbsp;Gabriella Castoria,&nbsp;Antimo Migliaccio","doi":"10.1016/j.steroids.2024.109380","DOIUrl":"10.1016/j.steroids.2024.109380","url":null,"abstract":"<div><p>Triple-negative breast cancer is a rare but highly heterogeneous breast cancer subtype with a limited choice of specific treatments. Chemotherapy remains the only efficient treatment, but its side effects and the development of resistance consolidate the urgent need to discover new targets. In TNBC, filamin A expression correlates to grade and TNM stage. Accordingly, this protein could constitute a new target for this BC subtype. Even if most of the data indicates its direct involvement in cancer progression, some contrasting results underline the need to deepen the studies. To elucidate a possible function of this protein as a TNBC marker, we summarized the main characteristic of filamin A and its involvement in physiological and pathological processes such as cancer. Lastly, we scrutinized its actions in triple-negative breast cancer and highlighted the need to increase the number of studies useful to better clarify the role of this versatile protein as a marker and target in TNBC, alone or in “collaboration” with other proteins with a relevant role in this BC subgroup.</p></div>","PeriodicalId":21997,"journal":{"name":"Steroids","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2024-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0039128X24000187/pdfft?md5=6097b8c143a580ec072c1ebbb0512ded&pid=1-s2.0-S0039128X24000187-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139681582","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Steroids
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1